STI Podcast
The STI Podcast, from BMJ Group, delivers the latest updates on the transmission, prevention, diagnosis, and treatment of sexually transmitted infections and HIV. Each episode features in-depth interviews with authors and leading experts, exploring recent research. It directs listeners to the STI journal website for further content. The podcast is intended for education and information, not as a substitute for medical advice.
Episodes
Escalating HIV Epidemic in Fiji
Fiji has been reporting a significant rise in the incidence of Human immunodeficiency (HIV) and hepatitis C virus (HCV) over the last 3 years. Health officials estimate that about 9,000 people are living with HIV in Fiji today, nearly 1% of the population. A startling 2,016 new cases of HIV alone were reported in 2025, compared to 1,583 cases in 2024. Among people starting HIV treatment in 2024,
Anal Intraepithelial Neoplasia in People Assigned Female at Birth
The experience of treating and/or losing a patient to anal cancer is deeply upsetting. Therefore, the early detection and treatment of precursors are of utmost importance to patients and clinicians. People with HIV have a higher prevalence and incidence of Human Papilloma Virus infection, an oncogenic virus, which may cause intraepithelial neoplasia, the precursor of squamous cell carcinomas in
Congenital Syphilis: No rest for the weary
Previously we reported on the Rise of Syphilis world wide. Today we focus on the devastating effects of syphilis on parents and their children. Hand in hand with an increase in syphilis incidence in adults the rates of congenital syphilis are rising and missed opportunities to test and treat birthing parents, their partners and babies are preventable contributing factors. Congenital syphilis is ca
WORLD AIDS DAY Pt 2: Progress towards an HIV cure
Continuing on the search for innovative strategies to shape the future of HIV cure research in the second part of this series, Dr Jillian Lau discusses how anti–PD1 immunotherapies and carefully designed treatment interruption studies are helping clinicians and scientists to better understand pathways to durable HIV remission. Dr Ming Lee then breaks down the results of the RIO study, highlighting
WORLD AIDS DAY Pt 1: Progress towards an HIV cure
In the first of this two-part series, we explore the latest advances in the search for an HIV cure. Professor Christian Gaebler shares insights from the remarkable case of the second Berlin patient —an individual cured of HIV following a stem cell transplant—and reflects on what similar cases mean for the future of curative strategies. We’re also joined by Professor Beatriz Mothe, who discusses th
Prevention of STIs in Trans and Gender Diverse People
Over the last decade we have seen an exponential surge in research and peer reviewed publications about the sexual health of trans and gender diverse people. We now know that sexually transmitted infections are highly prevalent in this key population and there is an urgent need for concentrated efforts made by patient advocates, health care providers, public health policy developers and government
Long-acting HIV Pre-exposure Prophylaxis
Most people requiring HIV pre-exposure prophylaxis (PrEP) are offered a daily or event driven oral tablet which contains two HIV antiretroviral drugs combined. Oral medication, however, may not be a feasible and/or effective PrEP option for some. FDA has approved two long-acting injectable HIV anti-viral drugs: Cabotegravir, an HIV integrase inhibitor (2 monthly injections) and Lenacapavir an HIV
Online Sexual Health Clinics: What works and what doesn’t
Worldwide the prevalence of sexually transmitted infections is increasing. Today we will discuss innovative ways of testing and treating large number of patients with STIs that are equitable, reliable and potentially cost-effective. We will discuss the eSexual Health Clinic (eSHC) research published in The Lancet Public Health in 2017 and NIHR funded SEQUENCE Digital research program based in UK
Testing for Blood Borne Infections in Antenatal Clinics
Today we will discuss the evolution and efficacy of antenatal testing for blood borne pathogens as a strategy to improve pregnancy outcomes and prevent parent to child transmission. Over the last 40 years the number of infections tested for in the antenatal setting has expanded which has been followed closely by treatment guidelines for each infection. However, there are stark regional differences
HIV and Syphilis Home Testing 101
Today we will discuss different types of HIV and Syphilis antibody testing performed at home by the patient or consumer. Home testing for HIV and Syphilis empower people, especially pregnant women who live in remote areas or are marginalised and hard to reach, to screen themselves for these two serious and communicable infections at home and seek additional confirmitory testing, treatment and supp
To Screen or Not to Screen?
Today we will discuss if screening asymptomatic Men who have sex with Men, also referred to as MSM, who are receiving HIV pre-exposure anti-retroviral medication, called HIV PrEP, routinely for bacterial STIs, gonorrhoea and chlamydia through pharyngeal, urine and rectal PCR testing every three months- also referred to as 3x3 testing is indeed of benefit or may cause harm. This year, in Lancet HIV
Novel antimicrobial approaches to Trichomoniasis
Today we provide you with an update on the sexually transmitted infection: Trichomonas vaginalis, a protozoan which infects the vagina, urethra and paraurethral glands. It is an uncommon cause of vaginal discharge and penile urethritis and can persist for a long time if left untreated. Up to 50% of people with vaginal infections and especially people with urethral infections remain asymptomatic. P
Revisiting gonorrhoea: Update on the 4CMenB vaccine for gonorrhoea prevention
You will recall a previous podcast about preventing Neisseria gonorrhoea through an effective vaccine. Neisseria gonorrhoeae is a ubiquitous sexually transmitted bacteria that can cause both localised and systemic disease if left untreated. It may be transmitted to neonates. We also reported on a rise of the gonorrhoea incidence, as well as increasing rates of antibiotic resistance.
Today we will
Beyond penicillin: are new antibiotics for syphilis on the horizon?
Today we will focus on the alternative treatments of early Syphilis. Worldwide many of us have experienced a shortage of gold standard treatment benzathine benzylpenicillin injections for syphilis. It is time we look for alternative antibiotic treatments and prevention strategies for syphilis. In conversation with Prof Jeffery Klausner, Professor of Medicine, Infectious Diseases and Public Health
WORLD AIDS DAY Pt 2: Growing Older with HIV
In our final episode in honour of the World AIDS Day we have a conversation with Assistant Prof. Rajasuriar, who coordinates the translational research program in HIV immunology and Ageing at the Centre of Excellence for Research in AIDS (CERiA) in Kuala Lumpur, Malaysia. Today, thanks to effective HIV antiretroviral therapy, people living with HIV can live long and healthy lives. According to the
WORLD AIDS DAY Pt 1: Managing HIV in Young People
Today we are honouring the World AIDS Day on 1st December in 2023, by focusing on young people who live with HIV. Adolescents and young people represent a significant share of people living with HIV worldwide. In 2022 alone, 255,000-760,000 young people between the ages of 10 to 24 were newly infected with HIV, of whom 35,000-250,000 were adolescents between the ages of 10 and 19. In conversation
IAS23 Conference Feedback in Brisbane, Australia in July 2023
Welcome to the 4th episode of the 2023 BMJ Sexually Transmitted Infections Podcast Series. This year the International AIDS Society Conference was held for the first time in Brisbane Australia in July 2023. It was wonderful to learn about many new research findings, community perspectives and to connect with old friends and make new ones. Today we will provide you with some of the many clinical, v
World Hepatitis Day 2023: Unveiling the Hidden Threats of the Hepatitis B Virus
In honour of World Hepatitis Day, today we focus on the Hepatitis B virus (HBV), a virus that can be transmitted through contact with infected blood and from mother to child during labour. HBV can also be transmitted sexually. It infects liver cells and causes both acute and chronic infections, which can be severe. Since HBV was discovered in 1965, we have made great progress in reducing the burde
A vaccine against gonorrhoea: Is it more than an aspiration?
Neisseria gonorrhoeae, in short NG, is a ubiquitous sexually transmitted bacteria that can cause both localised and systemic disease if left untreated. NG may also be transmitted vertically from mother to baby. Over the last years, we have seen a rise in the number of people diagnosed with gonorrhoea, alongside growing rates of antibiotic resistance. New research makes us hopeful that a vaccine ma
Rise of Syphilis
Welcome back to the 2023 BMJ STI Podcasts. Today we will focus on the worsening Syphilis epidemic worldwide. Syphilis is a bacteria that infects humans, and is transmitted horizontally through close sexual contact and vertically to unborn babies and neonates. It can cause acute and severe illness in those affected, such as neurosyphilis, and have tragic consequences for mother and baby. With the d
MPox 101, Community and Global response
Today we talk about transmission, diagnosis and management of MPox. We will also review the UK community and the World Health’s Organization's perspective on this virus. Please note that after the recording of this podcast the WHO implemented a change of the name of the virus to MPox.
Dr Fabiola Martin, STI's Podcast editor, interviews Dr Liesbeth Van Gestel, ID physician and clinical researcher
HIV and STI prevention, plus HIV in Ukraine
In this double-interview podcast, the Editor-in-Chief of the STI journal, Professor Anna Maria Geretti, brings you some of the highlights from the HIV Glasgow 2022 conference.
In the first interview (starting at 1:00), Professor Geretti interviews Jean-Michel Molina*, who discusses HIV and STI prevention.
The second interview (starting at 12:30) is with Professor Miłosz Parczewski**. They discuss
Bacterial STIs: The DoxyPEP Trial
Today we talk with the principal investigators of the DoxyPEP trial which was prematurely terminated due to its amazing success: participants receiving a stat dose of Doxycycline 200mg in less than 72 hours after condom-less sex were 63% less likely to develop a bacterial STI compared to participants in the control arm.
Prof Annie Leutkemeyer based in San Francisco (UCSF) and Prof Connie Celum, b
Presumptive and Prophylactic management of Bacterial STIs
Today we focus on presumptive and prophylactic management of bacterial STIs, talking with Dr Manoji Gunathilake, Head of sexual health services in Darwin, Australia, and Assistant Prof Will Nutland, the director of the NGO, the Love Tank, in London, UK.
Related links:
STI Guidelines Australia: https://sti.guidelines.org.au/
The Love Tank: http://thelovetank.info/
GRASP report: data to June 2021 ht
Preventing anal cancer in people with HIV: learnings from the ANCHOR study
In this podcast, we interview Professor Joel Palefsky about the ANCHOR study. Sexually Transmitted Infections' Editorial Fellow, Dr Ming Lee, speaks to the journal Editor in Chief, Professor Anna Maria Geretti, and Professor Palefsky, chief investigator of the randomised controlled trial, about the study which investigated treatment of anal high-grade squamous intraepithelial lesions (HSIL) to pre
HTLV2022: 20th International Conference on Human Retrovirology
Thank you for joining us for the HTLV2022 Conference review. Dr Fabiola Martin speaks to Joanna Curteis, the Australian patient representative, Dr Carolina Rosadas, researcher associate at National Centre for Human Retrovirology, Imperial College London, who specialises in HTLV-1 vertical transmission and Prof Damian Purcell. Damian's research group investigates the HIV-1 and HTLV-1 human retrovir
Mycoplasma Genitalium: Easy to detect, hard to treat
In this podcast, we focus on the bacterial genitourinary pathogen Mycoplasma genitalium (MGEN). We have known this pathogen for a long-time but only in recent years we have been testing and treating more frequently for this bacteria. In this conversation with Dr Fabiola Martin, STI's Podcast editor, Dr Emma Sweeney, Prof Catriona Bradshaw and Prof Nicola Low provide a clinical and research update
NATSAL-COVID: Britain’s National Surveys of Sexual Attitudes and Lifestyles
Today we focus on NATSAL and NATSAL COVID. These are Britain’s National Surveys of Sexual Attitudes and Lifestyles.
NATSAL has been undertaken every 10 years since 1990 and is a key data source for sexual and reproductive health policy development. However, the COVID-19 pandemic disrupted many aspects of sexual lifestyles, prompting the initiation of the NATSAL-COVID study with the aim of underst
World Human T Leukaemia Virus Day: patient, clinician and scientist’s perspectives
On the World HTLV Day (10th November), we focus on how the Human T leukaemia virus affects people, and review new developments in HTLV treatment and vaccination medicine. HTLV is a retrovirus similar to HIV which incorporates its DNA indefinitely into the human CD4 T lymphocytes. It is predominantly transmitted through condomless sex, but also from mother-to-child and through contact with HTLV pos
Impact of HIV infection on COVID-19 clinical outcome
In this podcast we discuss the reported impact of HIV infection on people who are hospitalised with COVID-19, by reviewing three publications:
1. Outcomes of COVID-19 Related Hospitalization Among People With HIV in the ISARIC WHO Clinical Characterization Protocol: A Prospective Observational Study. Clinical Infectious Diseases, 23 October 2020 (https://www.who.int/publications/i/item/WHO-2019-n
2021 World Hepatitis Day
On World Hepatitis Day 2021, we discover how Australian patients, patient advocates and health care providers are working together to reach the WHO elimination targets for chronic Hepatitis C virus infection.
Professor Gail Matthews, Infectious Diseases Physician and Program Head of Therapeutic Research and Vaccine Program at The Kirby Institute, Ms Carrie Fowlie, CEO of Hepatitis Australia, and
STI and HIV 2021 World Congress: taking virtual and accessibility to another level
July 2021 marks 40 years from the first reports of a 'strange disease' soon to be known as HIV/Aids. In this "very special edition" themed Sexual Diversity and the City, the STI & HIV 2021 World Congress is inviting people from all walks of life, with some being able to participate for free.
Listen to all the details in this conversation of STI's Social Media Editor Harrison Austin with Henry
HPV vaccine uptake: achievements and challenges
Today we focus on the challenges and success stories of HPV vaccine uptake, specifically in Italy and Australia. The HPV vaccine rollout has translated into a significant reduction in the prevalence of cervical and anal cancers. Since its discovery, many different strategies have been used to increase and maintain its uptake in school children, both girls and boys.
STI's Podcast Editor, Dr Fabiola
COVID-19 Vaccine and People who live with HIV
Thousands of people are currently being vaccinated against COVID-19 worldwide. In this podcast, we discuss if the authorised vaccines are useful to people who live with HIV.
STI's Podcast Editor, Dr Fabiola Martin, interviews Prof Anna Maria Garretti, Diseases at the Policlinico Tor Vergata, University of Rome Tor Vergata, Chair of the British HIV Association Vaccination Guidelines Panel, and Edit
HIV endemic in Indonesia: Are we there yet?
In this podcast, we explore how the HIV endemic has evolved over time in Indonesia and is tracking against UNAIDS 90:90:90 treatment for all goals. We discuss the impact the COVID-19 pandemic has had on the already stressed health care system in Indonesia.
Dr Fabiola Martin interviews Dr Keerti Gedela, Consultant physician and researcher in HIV and sexual health medicine, Chelsea & Westminster
Trans and Gender Diverse People and Health Care Services
In this podcast, we focus on why health care services need to adapt and provide inclusive and non-discriminating services for people independent of their gender or sexual preferences.
Dr Fabiola Martin interviews Dr Jae Sevelius, Associate Professor at the University of California San Francisco, USA, and Dr Graham Neilsen, Sexual Health Specialist at Royal Brisbane Women's Hospital and Stonewall
The U=U Message, ep. 3/3: a conversation with Prof Paul Volberding
In the third episode to honor World AIDS Day, on the 1st December, we are discussing the U=U message with Professor Paul Volberding, University of California San Francisco. We touch on the recently published multicentre study: Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries discuss by Okoli et al. Read the op
The U=U Message, ep. 2/3: a conversation with Brent Allan
In the second episode to honor World AIDS Day, on the 1st December, we are discussing the U=U message with Brent Allen, HIV patient representative. He explains why U=U means so much to people who live with HIV and those who are HIV negative.
Read the related paper: Undetectable equals untransmittable (U = U): Awareness and associations with health outcomes among people living with HIV in 25 countr
The U=U Message, ep. 1/3: a conversation with Chinyere Okoli
To honor World AIDS Day, on the 1st December, we are bringing you three special interviews over the next few days. In this first episode, we are discussing the U=U message with Chinyere Okoli, clinical pharmacist at ViiV Health care and principle investigator of the study: Undetectable equals untransmittable (U = U): Awareness and associations with health outcomes among people living with HIV in 2
Sexual health and COVID-19
Dr Fabiola Martin talks to Dr John McSorely about the rapid adjustments applied to UK's sexual health care services as a response to COVID-19 pandemic lockdown and deployment of sexual health care providers to support other health care services. They discuss implemented service innovations such as 'Digital First' and 'Telehealth'.
Dr John McSorley is a Consultant Physician in Sexual Health and HIV
HIV and COVID-19 - what do we know so far?
The original content of this podcast was removed in September 2022 after a participant withdrew their consent. This was the first in a series of podcasts on HIV and COVID-19 co-infection, and was recorded at a time when vaccines and treatments were not yet available. You can find later episodes on HIV and COVID-19 co-infection on the Sexually Transmitted Infections channel:
- https://soundcloud.c
Domestic violence affects a quarter of UK women: the role of sexual health practitioners
Two women die a week in consequence of domestic violence and abuse in the UK. It is increasingly recognised that enquiry by healthcare practitioners can enable pathways to earlier intervention and support.
Editor-in-Chief of Sexually Transmitted Infections, Jackie Cassell, is joined by two specialists in the field to discuss the special issue of the journal on domestic and intimate partner violen
A century of military sexual health: the origins of the speciality of venereal disease
Dr James Bingham, regarded by many as a father figure of the modern speciality, tells Lt Col Ngozi Dufty about the beginning of the field of venereal disease in the UK and how the origins of the sexual health service developed in consequence of the need to protect the health of the military troops first, and then the general population as a result.
This interview is one of two podcasts published
How we treat STIs: Centenary of The Venereal Disease Act
Dr. George Kinghorn, genitourinary medicine physician with 35 years' experience, talks to Dr. Maryam Shahmanesh (Consultant and Senior Lecturer at the University College London and Mortimer Market Centre) about the “dramatic changes” introduced in the treatment of STIs with the Venereal Disease Act 1917.
Professor George Kinghorn also analyses how the effects of the easier access to travel, the i
The Spectrum-STI model: gonorrhoea and syphilis prevalence trends in low and middle-income countries
How can burdens and trends of gonorrhoea and syphilis be estimated using surveillance data routinely collected in low- and middle-income countries?
Eline Korenromp, epidemiologist from the Avenir Health, Geneva, Switzerland, tells STI Editor Jackie Cassell how the Spectrum-STI tool, developed at request of the World Health Organization, facilitates standardised, country-level estimation of trends
How to integrate quality improvement into GUM and HIV services
Audit vs. Quality Improvement Methodology. How to undertake quality improvement and integrate it into GUM and HIV services?
Hanna Bos, from the Municipal Health Service of Deventer, The Netherlands, discusses with Anna Hartley, one of the authors of a article, which explores the premise that true quality improvement methodology is poorly understood and poorly used in the NHS.
Dr. Hartley, from
Digital tools: the future for partner notifications?
In this podcast, Jackie Cassell, the Editor in Chief of STI, talks to Anatole Menon-Johansson, from the Department of Sexual Health, Guy's & St Thomas’ NHS Foundation Trust, London, UK, about partner notification technologies.
The STI blog post "Improving Partner Notification with a new online tool from SXT Health CIC [Community Interest Company]" is the starting point for a broad conversatio
STI Outbreak Issue August 2016: two cases of success in England
In this podcast we explore the management of STI outbreaks. Ian Simms, of the HIV & STI Department, Public Health England, interviews two authors who have managed STI outbreaks.
Kirsty Foster, of the Public Health England North East, investigated an outbreak of gonorrhoea in young heterosexual adults in that area of the UK.
Read the full letter here: http://sti.bmj.com/content/92/5/364.full.
Sexual behaviour abroad: patterns revealed and advice for backpackers and other travellers
What do we know about sexual behaviour when travelling?
Are backpackers and gap year travellers a special group?
These are some of the questions Christopher Lewis, from the University of Birmingham, and Dr Clare Tanton, from the UCL's Centre for Sexual Health and HIV research, answer in this podcast.
They are the authors of two recent studies published at sti.bmj.com.
Read the full studies:
'
Ocular Syphilis: Unanswered Questions and the Role of HIV Co-Infection
In this podcast, Dr Khalil Ghanem discusses ocular syphilis with the authors of two studies. Dr Susan Tuddenham, from the Johns Hopkins University in Baltimore, Maryland, USA, is the author of 'Increasing Case Reports of Ocular Syphilis in the United States: An Opportunity to Address Important Unanswered Questions', accessible here: http://goo.gl/cPcbLM and Dr Motoyuki Tsuboi, from the AIDS Clinic
Sexual life of deploying US military shipboard populations
A lot has changed since the last study among shipboard populations has been conducted, about 20 years ago. What is the health of shipboard military personnel and why is it important to study their sexual health? How is life in a deployment? How can the findings of this study apply to civilian populations?
In this podcast, Judith Harbertson of San Diego State University and US Military HIV Resear
Seasonal differences in sexual behaviour and sexually transmissible diseases in Melbourne, Australia
In this podcast Dr Katy Turner talks to Dr Vincent Cornelisse about his recently published paper "Summer Heat: A cross-sectional analysis of seasonal differences in sexual behaviour and sexually transmissible diseases in Melbourne, Australia".
They discuss the seasonal differences in sexual activity and disease transmission across different sexual pairings and the seasons.
Full text: http://sti
ISSTDR conference - Jane Hocking
In this podcast Dr Katy Turner talks to Dr Jane Hocking at the ISSTDR conference in Brisbane, Australia. They discuss Dr Hocking's preliminary results from a Chlamydia screening trial across Australia and the logistics for testing and collecting data across such a large area.
ISSTDR conference - Hayley Denison
In this podcast Dr Katy Turner talks to PhD student Hayley Denison at the ISSTDR conference in Brisbane. They discuss the differences studying for a PhD in New Zealand compared to the UK and how social media has helped people keep up to date at conferences.
Sex, drugs, and men who have sex with men
How does drug use feed into STI transmission in men who have sex with men? What kinds of behaviours happen, and how can clinicians discuss these issues with men and best help them?
In this podcast Adam Bourne, London School of Hygiene & Tropical Medicine, and David Stuart, substance use lead at the 56 Dean Street sexual health clinic, discuss the issues and offer their advice.
Read the relat
The disruptive influence of syphilis cures within specialist venereal systems
Simon Barton, Clinical Director, HIV & Sexual Health, Chelsea & Westminster Hospital, London, talks to Joseph D Tucker, International Diagnostics Centre, Keppel Street, London, about his editorial on how the history of syphilis cures provides some guidance on preparing for a HIV cure. More information about the working group can be found here http://searchiv.web.unc.edu/
Read the full ed
Scrotal recall
Nicola Low, Professor of Epidemiology and Public Health at the Institute of Social and Preventive Medicine, University of Bern, Switzerland, talks to Tom Edge, writer of the Channel 4 sitcom Scrotal Recall, a drama where a young man explores his past relationships via contact tracing after discovering he has chlamydia.
Tom discusses the medicine and research behind the writing, and the tensions b
Gonorrhoea and chlamydia screening in HIV clinics: time for new tools and targets
Prevalence studies indicate approximately 10% of patients in HIV clinics may be infected with Neisseria gonorrhoeae (NG) and/or Chlamydia trachomatis (CT) at any given time, and a study recently published in STI by Burchell and colleagues reveals that a modest increase in testing in their clinic did not improve detection of CT and NG.
Khalil Ghanem, STI associate editor, asks Stephen Berry, Divis
The prevalence of and factors associated with paying for sex among men resident in Britain
STI associate editor Katy Turner talks to Kyle Jones, Infection & Population Health, University College London, about his studying examining who in the UK pays for sex.
Alcohol consumption and prevalence of human papillomavirus (HPV) infection among US men
Jennifer Smith, STI associate editor, talks to Matthew Schabath, H. Lee Moffitt Cancer Center & Research Institute, US, about his paper: Alcohol consumption and prevalence of human papillomavirus infection among US men in the HIM (HPV in Men) Study http://goo.gl/kVaHcm
The third National Survey of Sexual Attitudes and Lifestyles in the UK
Dr Clare Tanton, UCL's Centre for Sexual Health and HIV research, and Soazig Clifton, NatCen Social Research, both researchers on The National Survey of Sexual Attitudes and Lifestyles (http://natsal.ac.uk) join us to discuss the survey, how it was carried out, and some of the reaction to their findings.
Read the papers online:
What's new about Natsal-3: http://goo.gl/IDaRYN
Consistency in reporti
Chlamydia point-of-care tests in a tropical, low-resource setting
Barbara Van Der Pol, Associate Professor of Medicine, University of Alabama at Birmingham, and Dermot Hurly and Monika Buehrer-Skinner, both Anton Breinl Centre for Public Health and Tropical Medicine, James Cook University, have a conversation about issues related to chlamydia point-of-care tests and the need to continually assess the performance of these assays in real-use settings.
Read the ful
Trichomonas vaginalis
To go alongside this month's special STI issue on Trichomonas vaginalis, Dr Scott McClelland, Departments of Medicine, Epidemiology, and Global Health, University of Washington, and Prof Sharon Hillier, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, talk about our current understanding of the condition, and future clinical and academic directions.
View a
HPV vaccination for gay men
Mark Lawton, Mayura Nathan, and David Asboe, the authors of a recent editorial in STI, discuss why they think it's time to include young MSM in the national vaccination programme for HPV.
Read the full editorial: http://sti.bmj.com/content/89/5/342.full
STI in Vienna 2013 - Jonathan Ross
Seán Cassidy, doctor in GU medicine at Guys and St Thomas's NHS Foundation Trust, and social media editor for STI, talks to Jonathan Ross, a professor of Sexual Health and HIV based at University Hospitals Birmingham NHS Foundation Trust.
STI in Vienna 2013 - Marita Van Der Laar
Seán Cassidy, doctor in GU medicine at Guys and St Thomas's NHS Foundation Trust, and social media editor for STI, talks to Marita Van De Laar, Head of Program for HIV and Sexually Transmitted and Blood-Borne Infections in the Office of the Chief Scientist of the European Centre for Disease Prevention and Control (EDCD)
STI in Vienna 2013 - Katie Turner
Seán Cassidy, doctor in GU medicine at Guys and St Thomas's NHS Foundation Trust, and social media editor for STI, talks to Katie Turner, a National Institute of Health Research (NIHR) fellow, based in the Department of Social Medicine at the University of Bristol.
STI in Vienna 2013 - Myron Cohen
Seán Cassidy, doctor in GU medicine at Guys and St Thomas's NHS Foundation Trust, and social media editor for STI, talks to Myron Cohen,
Associate Vice Chancellor for Global Health and Director for the Center for Infectious Diseases at the University of North Carolina.
STI podcast: Non disclosure of HIV status in the clinic
In the UK, it is estimated that 24% of HIV positive patients are unaware of their infection. This figure is derived from statistical modelling, but how often do people who are identified as having been unaware of their infection are actually just non-disclosing instead? In this podcast Gary Brooks talks to Ann Sullivan from Chelsea and Westminster Hospital NHS Foundation Trust, about her research
STI podcast: Routine HIV testing for acute medical admissions
The 2008 UK National Guidelines for HIV testing recommended HIV testing should be offered to all general medical admissions aged 16–60 years in high prevalence areas, and that this should be evaluated to ensure this was effective in diagnosing previously undiagnosed HIV. In this podcast, Gary Brook talks to Adrian Palfreeman, University Hospitals Leicester, about his evaluation in the city.
STI podcast: Recent infection testing algorithm (RITA) tests for HIV
Katy Turner (NIHR research fellow, School of Social and Community Medicine, Bristol University) talks to Elizabeth Carlin (consultant in Genitourinary Medicine, Nottingham University Hospitals) about the possibilities, limitations and practicalities of using recent infection testing algorithm (RITA) tests to detect HIV.
Read the article online: http://tinyurl.com/b3tp9wu
STI podcast: Low sperm counts in genitourinary medicine clinic attendees
Peter Greenhouse (consultant in sexual health at Bristol Sexual Health Centre and Western) talks to Christopher Carne (consultant in the Department of Genitourinary Medicine, Addenbrookes Hospital, Cambridge University) about his recent case-controlled study looking at semen abnormalities in genitourinary medicine clinic attendees.
Read the article online: http://tinyurl.com/bgrvx8e
STI podcast: HIV/AIDS today and tomorrow
William Wong (Department of Family Medicine and Primary Care, The University of Hong Kong, Hong Kong, China) and Till Bärnighausen (Department of Global Health and Population, Harvard School of Public Health, Boston, Massachusetts, USA) discuss March’s STI HIV/AIDS themed issue.
They talk about patient perspectives of ART, the future of providing treatment in different countries and contexts, and
STI podcast: Running a prison sexual health service in the UK
Dr Alan Tang from Royal Berkshire NHS Foundation Trust, discusses approaches to setting up and running a prison based sexual health service with Éamonn O’Moore, unit director for Thames Valley Health Protection Unit of the HPA.
Read the article online: http://tinyurl.com/b6s2nv6
STI podcast: STI programmes in Latin America and the Caribbean
King Holmes (director, Center for AIDS and STD, University of Washington; past president of the IUSTI) talks to Patricia Garcia (dean of the School of Public Health, Universidad Peruana Cayetano Heredia, Peru; regional director for IUSTI in Latin America and the Carribbean) about the progress in treating STIs in Latin America and the Caribbean.
Professor Garcia discusses what a recent survey by Th
STI podcast: Australia’s HPV vaccination programme and disappearing genital warts
Dr Colm O’Mahony (consultant at the Countess of Chester Hospital NHS Foundation Trust, UK) talks to Professor Christopher Fairley (director of the Melbourne Sexual Health Centre, University of Melbourne, Australia) about the near disappearance of genital warts in Australia’s young women following the start of their human papillomavirus (HPV) vaccination programme.
They also discuss the UK’s decisi
STI podcast: Surveillance and treatment of antibiotic resistance
Catherine Ison and Gwenda Hughes, Health Protection Agency UK, and Craig Tipple, Imperial College London, discuss strategies for the surveillance and treatment of antibiotic resistance bacteria.
Read the article online: http://tinyurl.com/bfdnnf7
STI podcast: Recognising sexual addiction.
Michael Waugh discusses with David Goldmeier how to recognise sexual addiction in the sexual health clinic.
Read the article online: http://tinyurl.com/bahzwkv
STI podcast: Electronic records and sexual health outcomes
In this STI podcast, Andy Winter (consultant in sexual health and HIV, NHS Greater Glasgow and Clyde, UK) talks to Gary Brook (Central Middlesex Hospital, London, UK) about the effectiveness of electronic records in chlamydia and gonorrhoea treatment and partner notification.
Read the article online: http://tinyurl.com/b6edcd6
STI podcast: How you ask really matters
Cath Mercer, an associate editor with STI, asks Lisa Langhaug (Centre for Sexual Health and HIV Research, London, UK) about her work investigating the best way to ask Zimbabwean youth about their sexual health.
Read the article online: http://tinyurl.com/9wbsegt
